Green fluorescent protein fused to peptide agonists of two dissimilar G protein‐coupled receptors: novel ligands of the bradykinin B2 (rhodopsin family) receptor and parathyroid hormone PTH1 (secretin family) receptor. Issue 1 (4th October 2013)
- Record Type:
- Journal Article
- Title:
- Green fluorescent protein fused to peptide agonists of two dissimilar G protein‐coupled receptors: novel ligands of the bradykinin B2 (rhodopsin family) receptor and parathyroid hormone PTH1 (secretin family) receptor. Issue 1 (4th October 2013)
- Main Title:
- Green fluorescent protein fused to peptide agonists of two dissimilar G protein‐coupled receptors: novel ligands of the bradykinin B2 (rhodopsin family) receptor and parathyroid hormone PTH1 (secretin family) receptor
- Authors:
- Charest‐Morin, Xavier
Fortin, Jean‐Philippe
Bawolak, Marie‐Thérèse
Lodge, Robert
Marceau, François - Abstract:
- <abstract abstract-type="main" id="prp24-abs-0001"> <title>Abstract</title> <p>We hypothesized that peptide hormone sequences that stimulate and internalize G protein‐coupled receptors (GPCRs) could be prolonged with a functional protein cargo. To verify this, we have selected two widely different pairs of peptide hormones and GPCRs that nevertheless share agonist‐induced arrestin‐mediated internalization. For the parathyroid hormone (PTH) PTH<sub>1</sub> receptor (PTH<sub>1</sub>R) and the bradykinin (BK) B<sub>2</sub> receptor (B<sub>2</sub>R), we have designed fusion proteins of the agonists PTH<sub>1‐34</sub> and maximakinin (MK, a BK homologue) with the enhanced green fluorescent protein (EGFP), thus producing candidate high molecular weight ligands. According to docking models of each hormone to its receptor, EGFP was fused either at the N‐terminus (MK) or C‐terminus (PTH<sub>1‐34</sub>) of the ligand; the last construction is also secretable due to inclusion of the preproinsulin signal peptide and has been produced as a conditioned medium. EGFP‐MK has been produced as a lysate of transfected cells. Using an enzyme‐linked immunosorbent assay (ELISA) for GFP, average concentrations of 1.5 and 1670 nmol/L, respectively, of ligand were found in these preparations. The functional properties and potential of these analogs for imaging receptor‐expressing cells were examined. Microscopic and cytofluorometric evidence of specific binding and internalization of both fusion<abstract abstract-type="main" id="prp24-abs-0001"> <title>Abstract</title> <p>We hypothesized that peptide hormone sequences that stimulate and internalize G protein‐coupled receptors (GPCRs) could be prolonged with a functional protein cargo. To verify this, we have selected two widely different pairs of peptide hormones and GPCRs that nevertheless share agonist‐induced arrestin‐mediated internalization. For the parathyroid hormone (PTH) PTH<sub>1</sub> receptor (PTH<sub>1</sub>R) and the bradykinin (BK) B<sub>2</sub> receptor (B<sub>2</sub>R), we have designed fusion proteins of the agonists PTH<sub>1‐34</sub> and maximakinin (MK, a BK homologue) with the enhanced green fluorescent protein (EGFP), thus producing candidate high molecular weight ligands. According to docking models of each hormone to its receptor, EGFP was fused either at the N‐terminus (MK) or C‐terminus (PTH<sub>1‐34</sub>) of the ligand; the last construction is also secretable due to inclusion of the preproinsulin signal peptide and has been produced as a conditioned medium. EGFP‐MK has been produced as a lysate of transfected cells. Using an enzyme‐linked immunosorbent assay (ELISA) for GFP, average concentrations of 1.5 and 1670 nmol/L, respectively, of ligand were found in these preparations. The functional properties and potential of these analogs for imaging receptor‐expressing cells were examined. Microscopic and cytofluorometric evidence of specific binding and internalization of both fusion proteins was obtained using recipient HEK 293a cells that expressed the cognate recombinant receptor. Endosomal colocalization studies were conducted (Rab5, Rab7, β‐arrestin<sub>1</sub>). Evidence of agonist signaling was obtained (expression of c‐Fos, cyclic AMP responsive element (CRE) reporter gene for PTH<sub>1‐34</sub>‐EGFP). The constructs PTH<sub>1‐34</sub>‐EGFP and EGFP‐MK represent <italic>bona fide</italic> agonists that support the feasibility of transporting protein cargoes inside cells using GPCRs.</p> </abstract> … (more)
- Is Part Of:
- Pharmacology research & perspectives. Volume 1:Issue 1(2013:Oct.)
- Journal:
- Pharmacology research & perspectives
- Issue:
- Volume 1:Issue 1(2013:Oct.)
- Issue Display:
- Volume 1, Issue 1 (2013)
- Year:
- 2013
- Volume:
- 1
- Issue:
- 1
- Issue Sort Value:
- 2013-0001-0001-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2013-10-04
- Subjects:
- Pharmacology -- Periodicals
Drug development -- Periodicals
615.105 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2052-1707 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/prp2.4 ↗
- Languages:
- English
- ISSNs:
- 2052-1707
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4125.xml